Chi-Hsin R. King
Eli Lilly (United States)(US)Albany Molecular Research (United States)(US)
Publications by Year
Research Areas
Analytical Chemistry and Chromatography, TGF-β signaling in diseases, Microbial Natural Products and Biosynthesis, PI3K/AKT/mTOR signaling in cancer, Ubiquitin and proteasome pathways
Most-Cited Works
- → Optimization of a Dihydropyrrolopyrazole Series of Transforming Growth Factor-β Type I Receptor Kinase Domain Inhibitors: Discovery of an Orally Bioavailable Transforming Growth Factor-β Receptor Type I Inhibitor as Antitumor Agent(2008)66 cited
- → Dihydropyrrolopyrazole Transforming Growth Factor-β Type I Receptor Kinase Domain Inhibitors: A Novel Benzimidazole Series with Selectivity versus Transforming Growth Factor-β Type II Receptor Kinase and Mixed Lineage Kinase-7(2006)48 cited
- → [20] Purification of farnesylpyrophosphate synthetase by affinity chromatography(1985)17 cited
- → Synthesis of enantiomerically pure (+)- and (−)-18-methoxycoronaridine hydrochloride and Their preliminary assessment as anti-addictive agents(2000)14 cited
- → An affinity column for the purification of prenyltransferases(1985)3 cited